The Latest Breaking News from Clinical Trial

In a world first clinical trial, red blood cells that were grown in a laboratory have been transfused into two people.

Shares of oncology-focused biotechnology company Sonnet BioTherapeutics (SONN) have plummeted more than 70% in price year-to-date due to its poor financials and the broad-based market sell-off. However, the company is advancing its drug candidates via research breakthroughs, clinical trials, and strategic initiatives. Given the company’s constant progress, can this biotech…

An Australian-first clinical trial for a new needle-free COVID-19 vaccine has begun on the Sunshine Coast, in good news for those who fear the jab.

Australians living in regional and remote parts of the country could soon have access to specialised health care for diseases such as cancer as a Queensland-led telehealth program expands nationally.

Volunteers receive a transfusion of blood grown in a laboratory from stem cells of donors to see if it lasts longer than blood donated from a standard transfusion.

The FDA is taking a cautious approach to gene editing clinical trials in the United States, forcing companies to go overseas for early data generation.

Those who took a new drug during a clinical trial were found to have significantly lower blood pressure after other traditional medicines had failed.

Researchers said those given it during a clinical trial were found to have significantly lower blood pressure

Development delays across the pipeline risks losing interest on Wall Street, which has the attention span of a goldfish.

Scientists say that if proved safe, manufactured blood cells could revolutionise treatments for people with blood disorders

Two successful clinical trials of lab-grown red blood cells could revolutionise treatments for people with rare blood types amid an NHS shortage